| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1707 | 2019 |
| Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells K Ghoreschi, J Brück, C Kellerer, C Deng, H Peng, O Rothfuss, ... Journal of Experimental Medicine 208 (11), 2291-2303, 2011 | 415 | 2011 |
| Peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Δ12, 1412, 14-prostaglandin J2 ameliorates experimental autoimmune encephalomyelitis A Diab, C Deng, JD Smith, RZ Hussain, B Phanavanh, AE Lovett-Racke, ... The Journal of Immunology 168 (5), 2508-2515, 2002 | 372 | 2002 |
| T-bet is essential for encephalitogenicity of both Th1 and Th17 cells Y Yang, J Weiner, Y Liu, AJ Smith, DJ Huss, R Winger, H Peng, ... Journal of Experimental Medicine 206 (7), 1549-1564, 2009 | 351 | 2009 |
| T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity AR Gocke, PD Cravens, LH Ben, RZ Hussain, SC Northrop, MK Racke, ... The Journal of Immunology 178 (3), 1341-1348, 2007 | 343 | 2007 |
| Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. AE Lovett-Racke, JL Trotter, J Lauber, PJ Perrin, CH June, MK Racke The Journal of clinical investigation 101 (4), 725-730, 1998 | 335 | 1998 |
| Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? AE Lovett-Racke, Y Yang, MK Racke Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (2), 246-251, 2011 | 269 | 2011 |
| Peroxisome proliferator-activated receptor α agonists as therapy for autoimmune disease AE Lovett-Racke, RZ Hussain, S Northrop, J Choy, A Rocchini, L Matthes, ... The Journal of Immunology 172 (9), 5790-5798, 2004 | 253 | 2004 |
| Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity M Guerau-de-Arellano, KM Smith, J Godlewski, Y Liu, R Winger, ... Brain 134 (12), 3578-3589, 2011 | 243 | 2011 |
| Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes AE Lovett-Racke, AE Rocchini, J Choy, SC Northrop, RZ Hussain, ... Immunity 21 (5), 719-731, 2004 | 234 | 2004 |
| Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosis NJ Karandikar, MP Crawford, X Yan, RB Ratts, JM Brenchley, ... The Journal of clinical investigation 109 (5), 641-649, 2002 | 232 | 2002 |
| miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis KM Smith, M Guerau-de-Arellano, S Costinean, JL Williams, A Bottoni, ... The Journal of Immunology 189 (4), 1567-1576, 2012 | 213 | 2012 |
| Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated … H Peng, M Guerau-de-Arellano, VB Mehta, Y Yang, DJ Huss, ... Journal of Biological Chemistry 287 (33), 28017-28026, 2012 | 213 | 2012 |
| The mechanism of action of glatiramer acetate treatment in multiple sclerosis MK Racke, AE Lovett-Racke, NJ Karandikar Neurology 74 (1_supplement_1), S25-S30, 2010 | 153 | 2010 |
| Ligands for the peroxisome proliferator-activated receptor-γ and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis A Diab, RZ Hussain, AE Lovett-Racke, JA Chavis, PD Drew, MK Racke Journal of neuroimmunology 148 (1-2), 116-126, 2004 | 153 | 2004 |
| Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to … CT Harp, S Ireland, LS Davis, G Remington, B Cassidy, PD Cravens, ... European journal of immunology 40 (10), 2942-2956, 2010 | 143 | 2010 |
| miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing M Guerau-de-Arellano, H Alder, HG Ozer, A Lovett-Racke, MK Racke Journal of neuroimmunology 248 (1-2), 32-39, 2012 | 107 | 2012 |
| Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand AM Fenn, KM Smith, AE Lovett-Racke, M Guerau-de-Arellano, ... Neurobiology of aging 34 (12), 2748-2758, 2013 | 103 | 2013 |
| Silencing Nogo‐A promotes functional recovery in demyelinating disease Y Yang, Y Liu, P Wei, H Peng, R Winger, RZ Hussain, LH Ben, ... Annals of neurology 67 (4), 498-507, 2010 | 103 | 2010 |
| A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis E Fox, AE Lovett-Racke, M Gormley, Y Liu, M Petracca, S Cocozza, ... Multiple Sclerosis Journal 27 (3), 420-429, 2021 | 100 | 2021 |
